Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-21-015714
Filing Date
2021-06-25
Accepted
2021-06-25 17:26:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 mbrx20210622d_424b5.htm 424B5 353160
2 moleculinlogoresizedclear.jpg GRAPHIC 19339
  Complete submission text file 0001437749-21-015714.txt   380933
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-256627 | Film No.: 211049090
SIC: 2834 Pharmaceutical Preparations